| 臺大學術典藏 |
2020-03-06T05:26:38Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:33Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:31Z |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
Wu S.-G.; Gow C.-H.; Yu C.-J.; YIH-LEONG CHANG; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:29Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:16Z |
Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case
|
Gow C.-H.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; YIH-LEONG CHANG; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:01Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; YIH-LEONG CHANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:04:02Z |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.;Min-Shu Hsieh;Wu S.-G.;Shih J.-Y.; Gow C.-H.; MIN-SHU HSIEH; Wu S.-G.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-05T08:03:57Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Lin Y.-T.; Liu Y.-N.; Shih J.-Y.; MIN-SHU HSIEH; Gow C.-H. |
| 臺大學術典藏 |
2019 |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Shih J.-Y.; Chang Y.-L.; Gow C.-H.; Tsai T.-H.; Chang T.-H.; Liu Y.-N.;Tsai M.-F.;Shang-Gin Wu;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow, C.-H.;Chang, Y.-L.;Hsu, Y.-C.;Tsai, M.-F.;Wu, C.-T.;Yu, C.-J.;Yang, C.-H.;Lee, Y.-C.;Yang, P.-C.;Shih, J.-Y.; CHEN-TU WU; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, J.-Y.; Wu, S.-G.; Yang, C.-H.; Gow, C.-H.; Chang, Y.-L.; Yu, C.-J.; Shin, J.-Y.; Yang, P.-C.; YIH-LEONG CHANG; CHONG-JEN YU; PAN-CHYR YANG |
| 臺大學術典藏 |
2018-09-10T05:32:53Z |
Primary vascular leiomyosarcoma of the femoral vein leading to metastases of scalp and lungs (multiple letters) [4]
|
Gow, C.H.;Liaw, Y.S.;Chang, Y.L.;Chang, Y.C.;Yang, R.S.; YIH-LEONG CHANG; YEUN-CHUNG CHANG; RONG-SEN YANG |
| 臺大學術典藏 |
2018 |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Gow C.-H.;Liu Y.-N.;Li H.-Y.;Min-Shu Hsieh;Chang S.-H.;Luo S.-C.;Tsai T.-H.;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; MIN-SHU HSIEH; Chang S.-H.; Luo S.-C.; Tsai T.-H.; Chen P.-L.; Tsai M.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2017 |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.;Hsieh M.-S.;Wu S.-G.;Jin-Yuan Shih; Gow C.-H.; Hsieh M.-S.; Wu S.-G.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas
|
Gow C.-H.;Chang H.-T.;Lim C.-K.;Liu C.-Y.;Chen J.-S.;Jin-Yuan Shih; Gow C.-H.; Chang H.-T.; Lim C.-K.; Liu C.-Y.; Chen J.-S.; JIN-YUAN SHIH |
| 國立臺灣大學 |
2008-10 |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
Wu, S-G.; Gow, C-H.; Yu, C-J.; Chang, Y-L.; Yang, C-H.; Hsu, Y-C.; Shih, J-Y.; Lee, Y-C.; Yang, P-C. |
| 臺大學術典藏 |
2008 |
Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer
|
Chen C.-H.; Gow C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu Y.-C.; Lee W.-Y.; Yang P.-C.; Kuo S.-H.; Chen C.-H.;Gow C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu Y.-C.;Lee W.-Y.;Yang P.-C.;Kuo S.-H. |
| 臺大學術典藏 |
2008 |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
SHANG-GIN WU; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2006 |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; CHONG-JEN YU; Chen K.-C.; Yang C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2006 |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.; Chang Y.-L.; Shih J.-Y.; Gow C.-H.; CHONG-JEN YU; Yang C.-H. |
| 臺大學術典藏 |
2006 |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
PAN-CHYR YANG; Su W.-P.; Hsu Y.-C.; Chen K.-Y.; Chang Y.-L.; Tsai M.-F.; Yang C.-H.; Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Chang Y.-L.;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Pan-Chyr Yang; Shih J.-Y.; Gow C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2005 |
Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
|
Yu C.-J.; Chang Y.-L.; JIN-YUAN SHIH; Gow C.-H.; Gow C.-H.;Jin-Yuan Shih;Chang Y.-L.;Yu C.-J. |
